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Background Evaluations of large-scale health and nutrition programmes in
developing countries are needed for determining the effectiveness
of interventions. This article critically analyses a non-governmental
organization (NGO)-led large-scale, multi-country, 10-year
micronutrient and health (MICAH) programme with an ‘adequacy
evaluation’, that is, a documentation of time trends in the expected
direction.
Methods MICAH was implemented from 1996 to 2005 in selected areas of
Ethiopia, Ghana, Malawi and Tanzania, reaching46 million people
with numerous health and nutrition interventions. Coverage and
impact were monitored through surveys at baseline, midpoint and
end of funding. The data were subjected to post-hoc methods of
quality determination, and, if of suitable quality, included in the
adequacy evaluation.
Results Most collected data were of moderate or high quality and therefore
included in the adequacy evaluation. There were moderate to large
improvements in vitamin A status in Ethiopian school-age children,
children <5 years of age in Tanzania and Ghana and mothers in
Ghana. Iodine status improved in Malawi and Tanzania. Anaemia
rates and malaria prevalence decreased in women, pregnant women
and pre-school children in Ghana, Malawi and Tanzania, but anae-
mia increased in Ethiopian women. Large increases were reported
for rates of exclusive breastfeeding and immunization. Child growth
improved to the maximum that would be predicted with the
given interventions.
Conclusions Numerous nutrition and health impacts were observed in the inter-
vention areas, often of a magnitude equal to or larger than observed
in controlled interventions or trials. These results show the value of
integrated long-term interventions.
Keywords program evaluation, nutrition, public health, Africa, iron, vitamin A,
iodine, anaemia
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613Introduction
A recent series of publications in the Lancet has
described the scale of malnutrition in developing
countries,
1 the possible effects of successful nutrition
interventions on malnutrition
2 and some of the finan-
cial, bureaucratic and institutional hurdles preventing
implementation of these interventions.
3 One of the
key hurdles is the limited number of evaluations
of the effectiveness of large-scale multiple-
intervention nutrition programmes.
2 The lack of
effectiveness evaluations discourages investment in
nutrition programmes and precludes well-informed
decision making.
The efficacy of some single nutrition interven-
tions has been frequently and thoroughly evaluated
(e.g. iron supplementation,
4 vitamin A supplemen-
tation,
5 salt iodization
6). However, the effectiveness
(i.e. the efficacy in ‘real world’ settings) of large-scale
integrated health and nutrition programmes has
not been thoroughly evaluated.
2,7 Victora et al.
8 and
Habicht et al.
9 argue that evaluations of large-scale
programmes are necessary for determining the effec-
tiveness of interventions, and thus for deciding upon
resource allocation and public health programming:
‘In summary, there are important restrictions to the
external validity of RCTs [Randomized Controlled
Trials] for complex public health interventions. The
likelihood of effect modification implies that one
cannot take for granted that interventions that are
proven efficacious in controlled trials can be general-
ized to other settings’ (p. 403), although such
assumptions are in fact made.
2 Thus, there is a need
for high-quality evaluation of large-scale programmes.
However, such programmes are not usually led by
capable researchers with the budget and mandate to
evaluate programme effectiveness, but rather by pro-
gramme implementers without the budget, mandate
or skills to conduct the evaluation. As a result there is
a paucity of literature documenting the nutrition out-
comes of large-scale integrated nutrition and health
programmes.
2
The objective of this article is to provide evidence
of the effectiveness of a large-scale nutrition and
health programme in Africa. For this, we evaluated
a non-government organization (NGO)-led large-
scale, multi-country, 10-year comprehensive micronu-
trient and health (MICAH) programme, assessed with
an ‘adequacy evaluation’. Victora et al. define an
adequacy evaluation as, ‘documentation of time
trends in the expected direction, following
introduction of an intervention’ (p. 404).
8 Adequacy
evaluations have less rigorous designs than ‘plausibil-
ity evaluations’ and ‘probability evaluations’, which
provide the evaluator with a more confident assess-
ment of the programme’s impact. Included within
adequacy evaluation are ‘performance evaluations’,
which encompass evaluations of provision, utilization
and coverage, and ‘impact evaluations’, which
evaluate health outcomes and behaviours. Most of
the evaluations within this article are ‘adequacy
impact evaluations’, although immunization coverage
should be considered an ‘adequacy performance
evaluation’.
Prior to the evaluation, it was necessary to deter-
mine the quality of the evaluation data. Two specific
questions were considered: (i) are programme
evaluation data, collected by trained surveyors but
with less rigour than would be expected in a rando-
mized control trial, of sufficient quality to monitor
programme impacts? And if so, (ii) were the interven-
tions effective in improving the nutrition and health
of beneficiaries?
The MICAH programme was launched in 1995 by
World Vision Canada. The goal of the programme
was to improve the nutrition and health status of
women and children through the most cost-effective
and sustainable interventions, in line with interna-
tional targets set at the 1990 World Summit for
Children for the virtual elimination of vitamin A
and iodine deficiencies, and the reduction of iron
deficiency anaemia in women by one-third.
10
MICAH was implemented from 1996 to 2005 in five
African countries, four of which are reported here
(Ethiopia, Ghana, Malawi and Tanzania), reaching
4 million direct beneficiaries, and more than 6 million
indirect beneficiaries.
11,12 The fifth country, Senegal,
was of different structure and duration, consisting of
two 4-year interventions conducted in different areas,
rather than one longer intervention, and is therefore
excluded from this evaluation.
In this article, we evaluate the impact of MICAH
through a detailed assessment of programme evalua-
tion data, and we consider the implications for future
large-scale nutrition and health interventions.
Description of the MICAH programme
interventions
Considering baseline assessment of the vitamin A,
iron and iodine deficiencies epidemiology, and follow-
ing national policies, context-specific programme
plans were developed for each MICAH country
within a programme-wide framework of objectives
and strategies. Multiple interventions, ranging from
community-based supplement distribution to fortify-
ing and diversifying foods, and to national-level
advocacy for national policy change, were conducted
to address the deficiencies and target groups
identified. Interventions were integrated into existing
systems, structures and services, wherever possible, to
increase potential for sustainability. The interventions
not only had a shared purpose, but also had many
gross as well as nuanced differences based on country
context. Table 1 summarizes the MICAH activities: all
countries used multi-pronged integrated approaches
to address various aspects of nutrition and health.
Not all countries had the same target groups and
activities, but all had multiple targets and activities.
Programme areas within countries were poor rural
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ADEQUACY EVALUATION OF MICAH 615communities, where few or no other major develop-
ment organizations were operational. In Malawi and
Ethiopia, proposals were invited from other NGOs,
government organizations and local World Vision
units (‘Area Development Programmes’). In both
countries, programme areas were selected based on
quality of the proposals, evidence of community
need and applicants’ organizational capacity. In
Ghana, the Kwahu South district was selected as it
was known to have a high goitre rate, and World
Vision was working in the area on a water and
sanitation project. In Tanzania, the eastern zone was
selected by World Vision’s National Office, with the
agreement of the Ministry of Health, as an area in
need of micronutrient interventions. Further details
of each country programme are available in the
Supplementary data available at IJE online (see
Appendix 1).
A comparison of MICAH data with the Demographic
and Health Survey (DHS) data for national rural
samples (see Table 5) suggests that the selected
areas were similar to or worse off than the rural
average in each country at baseline. Ghana’s MICAH
baseline in 1997 was worse than the 1998 DHS rural
national numbers for immunization coverage, access
to protected water source (but not access to latrines)
and exclusive breast-feeding rates, with mixed results
for child growth status (better growth in height,
worse growth in weight). Tanzania’s baseline in
1997 was worse than the 1996 DHS rural national
numbers for access to protected water source and
latrines, and for child growth status. In Ethiopia
and Malawi the DHS data were available for the
follow-up year (2000) but not for the baseline year.
If the DHS data are extrapolated back to the baseline
year, assuming a linear trend, then 1997 MICAH indi-
cators in Ethiopia were worse than DHS for vitamin A
capsule (VAC) coverage in children <5 years of age,
and better for measles coverage and latrine access.
In Malawi, 1996 (extrapolated) DHS indicators were
better than MICAH for all available indicators, except
child growth, for which DHS and MICAH were
similar.
Methods
Sampling and data collection
Details of the methods for sampling, data collection
and data management are provided in the project
documents.
13 In brief, cross-sectional surveys were
conducted in each programme area, at baseline
(1996/97), the end of phase I (2000) and the end of
phase II (2004). The surveys were conducted in the
same month of the year in each country. Two-stage
cluster sampling was employed, in which clusters
were randomly selected using probability proportional
to population size. Key indicators were assessed
through structured interviews with a standardized
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616 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYquestionnaire, and collection of biochemical, clinical
and anthropometric data.
14
The sample sizes per country were between 900 and
4801 randomly selected households per survey.
Sub-samples for clinical and biochemical indicators
were randomly selected from the parent sample.
When there were multiple individuals of a given age
group in a household, one was chosen using standard
criteria, except for the immunization and anthropo-
metric indicators in which case all children <5 years
of age were included. Data were collected by trained
enumerators and clinical staff (varying by survey, but
including laboratory technicians, clinicians, nurses,
anthropometrists). More than two-thirds of immuni-
zation data were from child health cards, otherwise as
reported by the child’s parent. Child growth was
measured using calibrated Salter scales and locally
made length boards. Questionnaires were filled out
and anthropometrics taken at the subject’s house. In
some cases, the biological samples were collected from
the selected children when they were assembled at
local clinics or schools rather than at their homes.
Haemoglobin was measured using a portable
haemoglobin photometer: HemoCue B-Haemoglobin
photometer (HemoCue AB, Angelholm, Sweden)
15 in
Ethiopia (adjusted for altitude), Ghana and Malawi;
and Hemo-Control (EKF-diagnostic GmBH, Barleben,
Germany)
16 in Tanzania. Urine was collected from
school-age children for measuring urinary iodine.
Samples were transported to the laboratory, where
they were frozen until analysis with the Sandall–
Kolthoff reaction following digestion with ammonium
persulfate.
17 For breast-milk retinol, breast milk was
expressed from both breasts and a 20-ml sample was
collected in a foil-wrapped container, transported
with ice packs and then stored at –258C until labora-
tory analysis by high-performance liquid chromato-
graphy (HPLC).
18 Goitre was assessed by palpation
19
by trained team members or clinical officers, and
Bitot’s spots were observed
20 by trained nurses,
physicians or technicians. For malaria parasitemia,
capillary blood samples were smeared and stained
according to standard methods
21 and read by trained
technicians, who assigned a malaria parasites score of
‘present’ or ‘absent’.
Children’s heights and weights were converted to
standardized height-for-age Z-score (HAZ) and
weight-for-age Z-score [WAZ; the number of standard
deviations (SDs) the child’s height or weight is from
the reference population mean for children of the
same age],
22 using EpiInfo 6.04 (Centers for Disease
Control and Prevention, Atlanta, Georgia).
Data were entered by data clerks using standard
software (e.g. EpiInfo, MS Access, SPSS or CSPro);
10% of the data were double entered and checked
for accuracy. For key indicators with 410% data
entry error, data entry was manually checked. Initial
analyses were performed by statisticians using EpiInfo
or other statistical software. Additional cleaning and
analyses were done by World Vision Canada using MS
Access (various versions, Microsoft Corporation) and
SPSS (versions 10 and 11, Chicago: SPSS Inc.). The
results presented in this article are from this addi-
tional cleaning and analyses.
In all countries, the MICAH programme received
ethics clearance from the Ministry of Health. In
addition, local authorities, community leaders and
respondents were informed of the purpose of the
evaluation and consent was requested from each
individual respondent.
Quality control
MICAH evaluation survey data were collected by
trained enumerators, with field supervision by trained
programme staff and overall supervision and guidance
by an international team of epidemiologists,
nutritionists and statisticians. Accepted practices for
field-level quality control were followed.
14 However,
systematic repeat measures, repeat sampling and
inter-lab sampling were not available for quality con-
trol of the MICAH data. Therefore alternative, post-hoc
methods were used for evaluating the quality of data
collected. Some of these methods have been used
previously,
23 whereas others were developed for the
purpose of this evaluation. The methods were adapted
for each specific indicator, but are outlined in general
in Table 2. Not all variables were amenable to all
types of quality control checks.
Adequacy evaluation
The magnitude of the change for each key indicator
from baseline to follow-up to final survey was
compared with that observed in published controlled
trials and reports of other large-scale programmes
(Table 4). If improvement was of comparable magni-
tude to the high end observed in controlled trials, the
impact was considered ‘high’; if the improvement was
of a range common in other programmes, the impact
was considered ‘moderate’; if the change was smaller
than other programmes but greater than zero the
impact was considered ‘low’. Testing of differences
from baseline to follow-up was done by chi-square
for categorical variables and t-tests for continuous
variables.
Results
Quality control
Comparison of SDs
In most cases for which SDs could be calculated, the
MICAH values were within range of observed SDs in
published trials. Furthermore, the SDs were usually
relatively constant between survey years (Table 3).
Unusually high SDs (20-fold of that reported else-
where) were observed for breast-milk retinol in
Tanzania. The SDs for haemoglobin in pregnant
women in Ghana in 1997, Tanzania in 2000 and
ADEQUACY EVALUATION OF MICAH 617Ethiopia in 2000 as well as for children <5 years of
age in Ghana in 1997 were outside the range of SDs
reported elsewhere by –40 to þ15%.
Magnitude of change compared with other
programmes and trials
The magnitude of change in the MICAH indicators
was compared with what has been achieved in trials
and large-scale nutrition or health interventions
(Table 4). The Table 4 data were drawn largely from
a recent review
2 and the references therein. The
objective was to document the maximum impacts
observed, not necessarily the expected impacts, and
so only the highest efficacies are reported. No data
were found for nightblindness and Bitot’s spots in
school-aged children, or for malaria parasitemia in
non-pregnant women. Data were available for all
other indicators.
The maximum impacts observed in efficacy trials
were then compared with the changes observed in
MICAH (Table 5). Changes in MICAH, equal to or
greater than those observed in reviewed efficacy
trials, are shown in bold. Changes as large as those
observed in efficacy trials may initially be considered
‘questionable’—were there sampling biases in either
the efficacy trials or the MICAH sample? And if not,
Table 2 Methods used for quality control assessment
a
Method Expectations of high-quality data
  Comparison of magnitude of SDs of continuous
variables to SDs in other, well-controlled studies
  SDs of MICAH will be similar to others
b
  Consistency of relationships between coverage and
outcomes; congruency in chain of results
  Increased VAC coverage, iodized salt use and iron supplemen-
tation coverage will lead to decreased nightblindness and higher
breast-milk retinol, higher urinary iodine, and, possibly,
reduced anaemia, respectively
  Comparison of magnitude of apparent MICAH
effect to observed effects in efficacy trials
  Magnitude of MICAH effects will not greatly exceed maximum
magnitude of effects in efficacy trials
  Pattern of cross-sectional growth curves   Average HAZ and WAZ of infants <3 months of age will be near 0;
Z-score nadir reached between 12 and 24 months
  Change in average Z-scores by month of age will not fluctuate
widely
  Sample size at each age (by month) will be approximately equal
  Pattern of immunization coverage   BCG4DPT3 OPV35measles
aThese methods were developed post hoc. The acceptable levels (e.g. what constituted ‘similar’ or ‘widely’) were decided after the
analyses were done. Limits of this method are described in the ‘Discussion’ section.
bThis method of comparing SDs with reference populations has been recommended for anthropometrics.
23 We assume that
common levels of variations will exist for other variables.
BCG, Bacille Calmette-Gue ´rin Vaccine; DPT3, 3 doses of Diptheria, Pertussis, Tetanus Vaccine; OPV3, 3 doses of Oral Polio Vaccine.
Table 3 SDs of continuous variables in MICAH surveys in baseline (1996 or 1997), follow-up (2000) and endline (2004)
compared with examples from the literature, for quality control purposes
Ethiopia Ghana Malawi Tanzania
1997 2000 2004 1997 2000 2004 1996 2000 2004 1997 2000 2004 Examples
Breast-milk retinol
(mmol/l)
1.4 0.5 22.8 13.6 0.70, 0.48
35
1.19, 0.99
36
Urinary iodine—
school-age children
(mg/l)
25.4 140.0 132.1 76.9 98.0 20.5 38.9 145, 80,
37 48.1,
38
9.2–40.7,
39
40.4
40
Haemoglobin—
women (g/dl)
1.8 1.1 1.6 1.9 1.9 1.4 1.7 1.6 2.1 1.9 2.0 1.9
41
Haemoglobin—
pregnant women
(g/dl)
1.7 1.1 1.5 2.2 1.6 1.5 1.7 1.6 1.5 1.6 2.3 1.7 1.5,
421.8,
43 1.6
44
Haemoglobin—
children <5 years
of age (g/dl)
2.3 1.8 1.5 1.8 1.8 1.7 1.8 1.9 1.6 1.9
41
HAZ 1.5 1.4 1.3 1.2 1.2 1.5 1.5 1.2 1.5 1.5 1.3 1.84
23
WAZ 1.3 1.1 1.3 1.2 1.2 1.4 1.5 1.1 1.4 1.4 1.3 1.50
23
Unexpected or unusual values are indicated in bold.
618 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYcan impacts observed in effectiveness studies be as
large as those observed in efficacy trials? There
were questionable results in all four countries but
there were no indicators for which the results were
questionable in more than 3 countries. Within coun-
tries, there were as few as three and as many as six
questionable results. Whether these are false results
due to poor assessment or excellent results due to
strong programming is considered in the ‘Discussion’
Section.
Relationship between coverage and outcome
Changes in coverage data for vitamin A and iron
supplementation and iodine fortification correspond
to expected changes in outcomes in most cases
(Table 5, cells with non-concordance between pro-
gramme coverage and outcome indicator are
shaded). Increased coverage with VACs from one
survey to the next corresponded to decreased night-
blindness in Ethiopia and Tanzania and decreased
prevalence of low breast-milk retinol in Ghana.
Table 4 The maximum efficacy found in the literature for clinical, biochemical and biological indicators tracked in MICAH
Maximum efficacy observed
Indicator Controlled trials Large-scale programmes
Vitamin A
Night blindness in children
<5 years of age
From 1.2 to 0.1%
45
From 6 to 1.3%
46
From 2.3 to 0.6%
47
Bitot’s spots in children
<5 years of age
From 0.8 to 0.5%
45
From 6 to 1.3%
46
From 1.1 to 0.5%
47
Low breast-milk retinol From 70 to 36%,
48 from 25.6 to 15.2%,
49
similar and slightly different results
observed elsewhere
36,50
Iodine
Total goitre rate Although it is not uncommon to have no change in goitre prevalence,
34 marked
reduction
2,28 and near elimination
2,51 of goitre through long-term programmes is
achievable
Low urinary iodine From  25 to 0%
52 From 39, 56, 77 and 1.5% to  0%
34
Iron
Anaemia in women
15–49 years of age
From 7 to 1.6%;
9 46 to 19%
53,54 From 73.3 to 25.4%
54
Anaemia in pregnant
women
As high as from 70 to 10%;
4
73% reduction (RR ¼ 0.27) in pooled
analysis of iron folate supplementation
2
From 62 to 52%,
4 from 55 to 32%
55
Anaemia in children
<5 years of age
As high as from 72 to 19%;
4 from 38 to
62% reduction in non-malarial areas;
from 6 to 32% in malarial hyperendemic
areas
2
From 85 to 68%;
4 from 54 to 14%
56
Malaria
Malaria in pregnant
women
ITNs have protective efficacy of 0.26
57 for
malaria parasitemia
Malaria in children
<5 years of age
Average of protective efficacy of 0.13,
maximum of 0.57 with stable malaria and
0.42 with unstable malaria;
58 48% reduc-
tion in risk of clinical malaria through
intermittent preventive treatment (IPT)
2
Anthropometrics
HAZ < –2 Average increase in Z-score was  0.3, but single studies as high as 1.75.
59–61 When food
supplements delivered to food-insecure populations HAZ increased by an average of 0.41.
2
Increase of 0.3Z-score would lead to reduction in stunting of  10–15%.
WAZ < –2 Average increase in Z-score  0.3
(60, 61). Increase of 0.3Z-score would lead to
reduction in underweight of  10–15%.
Exclusive breastfeeding (EBF)
EBF for 6 months 0.6–7.9%;
25 Average odds ratio (OR) of
 3.5, maximum OR of 490 (40% in
intervention group, 0% in control)
2
As high as 46–68%
31
RR, Relative Risk.
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ADEQUACY EVALUATION OF MICAH 621An increase in the percentage of households with
iodized salt corresponded to decreased prevalence of
low urinary iodine in children in Malawi and
Tanzania but not Ghana. In Ethiopia, goitre rates
dropped despite the decrease in iodized salt in the
households and in Ghana goitre rates did not decrease
despite the increase in households with iodized salt.
An increase in iron tablet supplementation corre-
sponded with a decrease in anaemia prevalence in
seven of eight cases (that is, across countries for
pregnant women, non-pregnant women and children
<5 years of age, where supplementation and anaemia
data are available for 52 years). In all five cases
where malaria parasitemia data were available, an
increase in iron tablet supplementation and a
decrease in parasitemia corresponded to a decrease
in anaemia. In all four countries, an increase in
access to a protected water source and latrines corre-
sponded to decreased intestinal parasite infection.
Pattern of cross-sectional growth curves
For each country survey, average HAZ and WAZ and
sample size at 1-month intervals were plotted against
child age, and the plot was examined for the charac-
teristics described in Table 2. The data were then
scored as low quality (do not use), medium quality
(use with caution) or high quality. The Ethiopian
data were considered medium quality as many of
the child ages were reported by mothers, and they
appeared to be very often rounded to the half-year
and year. The 2004 data for age 448 months were
low quality (Z-scores higher than considered feasible).
The data from Ghana and Malawi were low quality at
age <6 months as there was a gain of  1Z-score
from birth to 4 months of age that is considered unli-
kely; otherwise the data were of high quality in all
three surveys. Tanzanian data were high quality in all
three surveys.
Immunization coverage
In all cases, except Ethiopia 2004, the MICAH
immunization coverage rates followed the pattern
of BCG4DPT3  OPV3 5measles. Furthermore, the
ratio of coverage of BCG:measles was between 1.0 and
1.3 in all cases. Overall, the MICAH immunization
data were considered reliable and useable for evalua-
tion purposes.
Adequacy evaluation
The MICAH programme impact in each country is
summarized in Table 6, where the change in each
indicator over the course of the intervention
(appearing in Table 5) is graded as high, moderate,
low, none or negative, and the quality of the data
supporting the claim is rated as high, medium or low.
There were moderate improvements in vitamin A
status in Ethiopian school-age children, and high
improvement in vitamin A status of Ethiopian chil-
dren <5 years of age and Ghanaian mothers.
Nightblindness dropped to zero in Tanzanian children
<5 years of age (P40.05). Iodine status improved in
Ethiopia, Malawi and Tanzania. Anaemia rates
decreased in women, pregnant women and pre-school
children in Ghana, Malawi and Tanzania, but increased
in Ethiopian women. Malaria prevalence dropped in
the same groups. Large increases were reported for
rates of EBF and immunization rates and child
growth status also improved in all countries.
Discussion
Integrated nutrition programmes are commonly
recommended for developing countries, but they are
not commonly implemented and even more rarely
evaluated. A recent review identified 30 large-scale
nutrition programmes, most of which did not have
strong designs for monitoring and evaluation.
2
The MICAH programme appears to be unique in
that it was an NGO-led multi-year, multi-country
integrated nutrition and health intervention with
monitoring of numerous clinical, biochemical and
behavioural indicators. The data were collected for
results-based management purposes, and as part of
the contractual requirements of the donor, and have
been reported in detail to the donor. In this study, we
considered whether the evaluation data were of
sufficient quality to evaluate programme impacts,
and, if so, the direction and magnitude of the
impact—an adequacy evaluation.
Post-hoc assessment of quality of data
collected
Most of the collected data were considered of good
quality, according to the methods used in this article
(Table 2). The important exceptions included anthro-
pometric data in Ethiopia, anthropometric data for
children <6 months of age in Ghana and Malawi,
breast-milk retinol analysis and urinary iodine in
Tanzania and EBF data in all countries. There may
have been poor laboratory practices in Tanzania for
breast-milk retinol and urinary iodine, and other
published evaluations of the quality of retrospective
EBF data
24–26 cast doubt on all retrospective exclusive
breastfeeding data. In addition, breast milk retinol
data and urinary iodine data in Tanzania were of
very low quality and were excluded from the
adequacy evaluation.
Based on the quality checks carried out in this
study, it appears that the following micronutrient
indicators are of sufficient quality when collected by
programme-based organizations (such as NGOs) if
adequate training and quality control measures are
taken during the data collection: for vitamin A
status—clinical indicators (night blindness, Bitot’s
spots); for iodine status—goitre; and the biochemical
indicator of anaemia as a proxy for iron status.
In addition, anthropometric indicators can also be
622 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYreliably collected for children between 6 and
59 months of age. Health indicators such as malaria
and immunizations coverage also appeared to be
of adequate quality.
Although the quality checks employed here
(Table 2) cannot replace standard methods of
repeat measures, inter-laboratory comparisons,
inter-observer reliability tests and others, they do
offer a relatively inexpensive and easily applied
means of post-hoc data quality assessment. These qual-
ity check analyses allow the assessment of the impact
of MICAH to be conducted with more confidence.
Furthermore, the analyses give confidence that
future surveys carried out by World Vision, or by
other similarly staffed and resourced NGOs, can be
done with sufficient accuracy and reliability for an
adequacy evaluation.
However, these post-hoc methods are limited by their
subjectivity, such as choosing the cut-offs used for
magnitude of SDs, deciding what constitutes a con-
sistent relationship between coverage and outcome,
the maximum feasible magnitude of change for each
indicator and the definition of an acceptable level
of fluctuation in average Z-score between months.
These were all determined after the analyses were
completed and there are no existing guidelines.
Further research is needed to provide standards and
guidelines on such post-hoc methods. Having stan-
dards and guidelines could increase the reliability of
data collected by non-research and/or programme
institutions without adding significantly to the cost
of data collection.
Adequacy evaluation
Magnitude of impact
Based on the finding that most of the indicators were
of good quality, an evaluation of the change in indi-
cators over time (adequacy evaluation) revealed many
positive results in the MICAH programme (Tables 5
and 6).
MICAH programme staff reported five aspects of
the programme that they believe uniquely contributed
to the positive results: (i) results-based management
identified programme activities that were not produ-
cing positive outcomes and allowed for mid-stream
corrections, such as the decision in Malawi (following
the 2000 evaluation) to reduce the geographic spread
Table 6 Summary of impact of MICAH, by indicator and country
Ethiopia Ghana Malawi Tanzania
Vitamin A
Night blindness in children <5 years of age High
a Low
a
Bitot’s spots in children <5 years of age High
a High
b
Night blindness in school-age children Moderate
a
Bitot’s spots in school-age children Moderate
a
Low breast-milk retinol High
b Not assessed
d
Iodine
Total goitre rate Low
a None
a High
a High
c
Low urinary iodine Low
a High
a Not assessed
d
Iron
Anaemia in women 15–49 years of age Negative
a High
a Low
a Moderate
a
Anaemia in pregnant women High
a High
a Low
a
Anaemia in children <5 years of age High
a High
a Low
a
Malaria
Malaria in women High
a High
a
Malaria in pregnant women High
a High
b
Malaria in children <5 years of age High
a High
a High
b
EBF for 6 months High
c High
c High
c Low
c
Immunization High
a Low
a Moderate
a Low
a
Anthropometry in children
HAZ < –2 None
b Low
a High
a High
a
W A Z<– 2 Low
b High
a High
a High
a
High, moderate, low, none and negative indicate magnitude of change in indicators. High: similar to upper end of impact of
controlled trials; moderate: less than trials and of a range common in other programmes; low: small effect, but greater than zero. t-
tests conducted for continuous variables and chi-square tests for categorical variables. Results with P<0.05 indicated with bold
text. Quality of data:
ahigh quality;
bmoderate quality;
clow quality;
dtoo poor quality to assess impact.
ADEQUACY EVALUATION OF MICAH 623and intensify the intervention in a smaller area to
ensure all participants received all interventions;
(ii) provision of regular, intensive technical support
in the form of regular email correspondence, monitor-
ing and support visits by World Vision technical
staff and expert consultants, and annual training
workshops; (iii) use of a broad-based integrated
package of interventions rather than relying on a
single ‘magic bullet’; (iv) community participation in
programme design, implementation and monitoring
and evaluation, such that some interventions could
be tailored to suit community preferences, especially
regarding animal husbandry where existing practices
differed from community to community; and (v) reg-
ular supervision of staff in communities. Other
aspects of the intervention, such as having competent
staff, effective supply chains and proper financial
controls are always prerequisites for success, though
not unique to MICAH’s success.
In Malawi there was a positive impact on all
indicators, perhaps a result of higher investment per
direct beneficiary compared with the other countries,
as well as MICAH’s support for the National
Micronutrient Coordinator position housed within
the Ministry of Health and Population that led to
concurrent positive developments in national nutri-
tion policy and action. In Ghana and Tanzania,
improvements were observed in vitamin A, iron,
malaria, EBF, immunization and child growth
status. There were fewer positive results in Ethiopia,
which may be because the intervention efforts were
‘diluted’ over a larger number of beneficiaries.
However, there was positive impact on vitamin A
status in school-age children—an uncommon target
and an uncommon success.
It has been estimated that  US $5 10/head/year is
a workable level of expenditure in nutrition pro-
grammes,
27 and Malawi, the one MICAH country
with costs that fell within this range, had the broad-
est range of positive results and overall impact
appeared correlated with per capita expenditures.
Vitamin A
Decreases in clinical symptoms of vitamin A are sim-
ilar to those found in other large-scale programmes.
The xerophthalmia results in Ethiopia were better
than observed previously (Table 4), but considering
the 10-year duration of the intervention the large
effect reported is feasible.
The logistics of breast-milk collection and storage
were difficult, as was measuring retinol in the
samples. The breast-milk retinol data collected were
considered of moderate quality (Ghana) or too poor
quality to use (Tanzania). Breast-milk retinol data
should perhaps be reserved for research/controlled
trials, with other indicators being used for programme
monitoring.
Coverage of children <5 years of age with vitamin A
supplements increased greatly in Ethiopia, Ghana and
Tanzania (from 9 to470%), although it dropped in
Ghana in 2004 to 26% when a novel method of
distribution was tested. Coverage with supplements
to new mothers increased in Ethiopia, Ghana and
Tanzania from  10 to 40–83%, an effect likely related
to the introduction by MICAH of community-based
distribution alongside facility-based distribution.
There was a concomitant improvement in vitamin A
status in Ethiopian children <5 years of age
(P<0.001) and of school age (P<0.001), and in
Ghanaian post-partum women (P<0.001), but not
in children<5 years of age in Ghana (P¼0.53) and
Tanzania (P<0.001) (although observed xerophthal-
mia dropped to zero).
Iodine
There were improvements in iodine status in Malawi,
consistent with improvements observed elsewhere
when successful long-term salt iodization pro-
grammes are in place.
6,28,29 In Malawi, the MICAH
programme had a particularly strong focus on
increasing usage of iodized salt (increased household
coverage from 59% in 1996 to 88% in 2004) through
efforts at multiple levels (i.e. national, regional and
community), as well as ensuring provision of iodized
oil capsules in areas where iodine deficiency disorder
was a severe public health problem. National-level
advocacy facilitated full implementation of salt iodi-
zation legislation. District-level customs and border
control staff and port authority health inspectors
implemented testing of salt at border crossings.
Intensive community education and regular monitor-
ing of salt at the vendor and household levels
increased consumer awareness and demand for
iodized salt. In contrast, although iodine deficiency
was a major concern of MICAH Ethiopia, there was
decreasing iodized salt available at household level
(i.e. 48% in 1997 decreased to 2% in 2004) due to
conflict with neighbouring Eritrea, their traditional
supplier of iodized salt, and lack of identification of
adequate alternate sources of iodized salt. Neither
Ghana nor Tanzania had major public health prob-
lems with iodine deficiency at the beginning of the
programme, based on goitre rates (i.e. 2 and 9%,
respectively). In Ghana, a reliable iodized salt supply
was difficult to secure, as there are many small-scale
producers in the country and existing salt iodization
legislation is difficult to enforce, although household
supply increased from 33 to 63% during the pro-
gramme. This was due to strong programme
advocacy efforts at the national level and collabora-
tion with one of the major iodized salt suppliers
in the country to provide increased supply to the
targeted district.
In Tanzania, the prevalence of goitre was reduced to
0%, perhaps due to the programme emphasis on
ensuring communities’ access to iodized salt (i.e.
household salt coverage increased from 41% in 2000
to 72% in 2004).
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In project areas of Ghana, Malawi and Tanzania,
where anaemia was identified as a severe public
health problem, programme resources were focused
on decreasing anaemia and subsequent decreases in
anaemia prevalence were observed. This is a particu-
larly important finding, as anaemia is often very diffi-
cult to address—although this magnitude of change is
not unprecedented (Table 4), it is uncommon. The
improvements observed in MICAH are likely a result
of the use of multiple strategies (supplements, animal
source foods, fortification, malaria control, water qual-
ity improvement, sanitation, deworming) over a long
intervention period. Furthermore, treating not only
pregnant women but also non-pregnant adult women
with iron supplementation allows for improved iron
status before pregnancy, making it easier to prevent
anaemia in pregnancy
30 and may explain the unusu-
ally large improvement in anaemia rates in pregnant
women of Ghana and Malawi despite high prevalence
of HIV/AIDS in the latter country.
EBF
The large increases reported in EBF are relatively high
compared with other interventions (of much shorter
duration).
25,31 Self-reports on duration of exclusive
breastfeeding have been shown to have low
32 to mod-
erate
24 accuracy (whereas duration of any breastfeed-
ing has higher accuracy).
24,26 Although over-reporting
of EBF duration may be expected as promotional mes-
sages sensitize mothers to the ‘right’ answers, this
does not necessarily occur.
33 Although acknowledging
the potential weakness of EBF data, MICAH’s
focus on breastfeeding communication through
community-based interventions for behaviour change
[e.g. through women’s groups, community health
workers (CHWs) and volunteers, traditional birth
attendants, agricultural extension workers] in all
countries and partnerships in Ghana and Malawi
with the Baby Friendly Hospital Initiative—in which
baby friendly practices were promoted not only in the
hospitals but also in health centres that provided out-
reach services by trained nurses to pregnant women
and new mothers in rural communities—is likely to
have contributed to improved infant feeding practices.
Immunization
MICAH supported the delivery system (cold chain
equipment, monitoring, per diems), and put extensive
efforts into social mobilization and community edu-
cation. This likely contributed to improvements in
immunization coverage in all four countries (high in
Ethiopia, moderate in Malawi, low in Ghana and
Tanzania).
Anthropometry
Perhaps the most important indicator of all is child
growth status, as it integrates the health effects of all
the interventions. Stunting and underweight were
reduced in all countries by 510%, except Ethiopia.
Improved dietary diversification was promoted for
children <2 years of age, utilizing food demonstra-
tions and nutrition education to caregivers to promote
improved infant and complementary feeding
practices, including a revolving fund to increase
household access to animal source foods in Ghana,
Malawi and Tanzania. Infant and young child feeding
was also an emphasis of the programme in Ghana,
Malawi and Tanzania, through women’s groups, edu-
cation through CHWs and volunteers, and agricultural
extension workers (Malawi), as well as through sup-
porting the Baby Friendly Hospital Initiative (Ghana
and Malawi), and forming mother support groups in
communities (Ghana and Tanzania). The smaller
impact on child growth in Ethiopia is consistent
with less emphasis placed on infant and young child
feeding. Reduced illness frequency and parasitic infec-
tion also likely contributed to the improvement in
growth, given the programme’s emphasis on water,
sanitation and deworming.
Bhutta et al.
2 developed a model predicting the
reduction in stunting with a large-scale programme
comprised of eight types of interventions: balanced
energy–protein supplementation, intermittent preven-
tive treatment of malaria, multiple micronutrient sup-
plementation in pregnancy, breastfeeding promotion,
complementary feeding and other supportive feeding
strategies, vitamin A and zinc supplementation and
hygiene intervention. If coverage of all eight inter-
ventions was 99 or 70% then the relative reduction
in prevalence of stunting at 12 months would be
33 and 23%, at 24 months 36 and 24% and at
36 months 36 and 24%, respectively.
2 Over the
10-year MICAH programme (which included four of
the eight interventions in the Bhutta model, plus
other components) this theoretical maximum reduc-
tion in prevalence of stunting of 24–36% after 3 years
was approximated in Malawi (15%), Ghana (28%),
and Tanzania (36%). This is most encouraging and
points again to the potential impact of multiple,
integrated strategies.
Attribution
The question of ‘attribution’ of improvements is not
easy to answer. An adequacy evaluation is not
designed to enable attribution, as other confounding
factors have not been controlled for: a plausibility
evaluation would be required. In MICAH’s case, for
example, concurrent activities and inputs by other
international (e.g. UNICEF) and national (e.g.
Ministry of Health) actors would also have contrib-
uted to improvements; also, there were some
improvements in average socio-economic status of
beneficiaries over time, which, independent of
MICAH, could have contributed to improved water
and latrine access, ITN usage and child growth
status. However, the MICAH programme was imple-
mented in predominantly rural areas where existing
ADEQUACY EVALUATION OF MICAH 625government nutrition and health services were gener-
ally weak. In an attempt to estimate the impact of
MICAH independent of other local and global influ-
ences, comparisons were made with DHS data for the
national, rural samples. The change in those indica-
tors for which there were both MICAH and DHS data
at baseline or follow-up and endline is shown in Table
7 as the difference of the differences (the difference
between the MICAH difference between endline and
baseline and the DHS difference between endline and
baseline). For most indicators in all four countries,
MICAH areas outperformed rural areas of the country
as a whole. Although the comparison groups are not
perfectly suited as control groups (different years, dif-
ferent baseline conditions, other differences not
related to MICAH), given the MICAH performance
compared with the DHS along with the general con-
cordance between coverage and outcome indicators in
the MICAH samples, it does support the interpretation
that the improvements in programme beneficiaries are
greater than the general trends, and greater than
would have occurred if MICAH was not implemented.
Was this an adequacy evaluation?
Although this evaluation has documented the trends
over time, it still perhaps falls short of a full adequacy
evaluation according to the prerequisites proposed by
Victora et al.: ‘(i) the causal pathway must be rela-
tively short and simple, (ii) the expected impact must
be large and (iii) confounding must be unlikely’.
8
These prerequisites are vague and open to
interpretation.
The first criteria proposed by Victora et al. would not
be met, as in the MICAH programme the causal path-
ways are variable, ranging from the very short and
direct (e.g. MICAH-funded staff supervising the
distribution of MICAH-purchased VAC to school-aged
children in MICAH communities to decrease clini-
cal symptoms of vitamin A defieciency among
school-aged children), to long and indirect (e.g.
MICAH partners using MICAH-financed training
materials to advocate for salt iodization to increase
availability of iodized salt at the household level to
decrease goitre rate), where the health impact, if
any, cannot clearly be attributed to the availability
of training materials. In addition, the use of multiple,
integrated strategies precludes the evaluation of any
one intervention’s causal pathway.
The second criterion, that expected impacts be large,
is also not consistent, as expected impacts are variable
in the MICAH programme. It is not uncommon for
salt iodization programmes to virtually eliminate low
urinary iodine.
34 On the other hand, improvements in
growth status in previously published research are, on
average,  0.3Z-scores, which may be about one-third
to one-sixth of the population standard deviation.
However, the sample sizes chosen provided adequate
power in most cases such that statistical tests of pro-
grammatically important changes had results with
P<0.05.
The third prerequisite, that confounders are
unlikely, is most certainly not met, as confounding
(i.e. effects from multiple sources) is likely for many
of the indicators. However, it is interesting that pro-
gramme success was observed in those indicators
most open to confounding (growth status, anaemia)
as well as those least open to confounding (e.g. night-
blindness, urinary iodine).
Thus, perhaps not a ‘perfect’ adequacy evaluation,
the analyses and interpretation presented here are
useful in assessing the quality of MICAH monitoring
and the level of impact, and strongly suggest
Table 7 Difference in differences of coverage rates, EBF and prevalence of stunting, wasting and underweight between
MICAH surveys and DHS surveys
a
Ethiopia
b Ghana
c Malawi
d Tanzania
e
VAC coverage, children <5 years of age 16
VAC coverage, post-partum women 10
Measles coverage 44 –5 13 7
Access to protected water source 41 20 –2 –4
Access to latrines –10 2.5 2 –7
EBF for 6 months 9 14
Stunting (HAZ <–2) –4 0 3 9
Underweight (WAZ <–2) –6 8 10 11
aCalculated in general as (EndlineMICAH–BaselineMICAH) – (EndlineDHS – BaselineDHS) for those variables where ‘higher’ is ‘better’.
For stunting and underweight, where ‘lower’ is better, calculated as: (EndlineDHS – BaselineDHS) – (EndlineMICAH–BaselineMICAH).
A positive value indicates that MICAH villages improved more than the rural, nationally-representative, samples. DHS data used
when available within 1 year of timing of MICAH survey; DHS data not available in baseline years for Ethiopia and Malawi,
therefore mid-line year (2000) used as ‘baseline’ in calculation.
b(2004MICAH-2000MICAH) – (2005DHS – 2000DHS).
c(2004MICAH-1997MICAH) – (2003DHS – 1998DHS).
d(2004MICAH-2000MICAH) – (2004DHS – 2000DHS).
e(2004MICAH-1997MICAH) – (2004DHS – 1996DHS).
626 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYimportant positive changes of micronutrient status
during the MICAH programme.
Conclusion
In conducting an adequacy evaluation we
documented trends in health indicators following
introduction of the MICAH programme. In doing so
we have established World Vision’s capacity for
undertaking such evaluations and we expect other
similarly positioned NGOs to be able to implement
similar evaluations. The challenge in future assess-
ments will be to determine the most appropriate key
indicators to measure impact, to improve the quality
of the data collection and management so that all of
the data are of high quality and to strengthen the
study design to enable ‘plausibility’ and ‘probability’
evaluations.
8
The rating of the magnitude of changes as high,
moderate or low was, of course, subjective.
Considering the specific characteristics of MICAH, it
is a challenge in the interpretation to determine if the
‘questionable’ changes (i.e. improvements greater
than observed in efficacy trials) were real results
due to excellent programming or false positives due
to limitations in the data collection methods. The
duration of MICAH was longer than almost all the
efficacy trials reviewed, and MICAH simultaneously
addressed numerous aspects of nutrition and health,
thus results larger than those reported in the pub-
lished literature on single interventions are feasible.
Therefore, unless there were specific, known prob-
lems, the results are considered to be valid, whereas
it is acknowledged that there may be false positives.
Further research on broad-based, long-term interven-
tions is required to quantify maximum magnitude of
impacts that may be feasible through long-term inter-
ventions. Presumably with a very successful,
broad-based long-term intervention, the end points
can be similar to the nutrition and health situation
in developed countries (e.g. no goitre, anaemia prev-
alence <5%).
In conclusion, we have identified three lessons from
this work. First, post-hoc methods appear reasonable
and feasible for quality control assessment, but fur-
ther research is required for standardization of the
cut-offs and limits for the methods described in
Table 2. Secondly, NGOs that are capable of executing
large-scale health interventions can also be capable of
conducting adequacy evaluations, using similar levels
of support as MICAH, if planned for from the begin-
ning. Thirdly, for programme implementation, inte-
grated nutrition and health interventions can
produce excellent results, perhaps even greater than
randomized controlled trials. Further operational
research quantifying the magnitude of the effective-
ness of integrated programmes is required.
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KEY MESSAGES
  This article complements the sparse literature on evaluations of large-scale nutrition and health
programmes, through the ‘adequacy evaluation’ of an NGO-led, large-scale, multi-country, 10-year
nutrition and health programme.
  Post-hoc assessment of data quality indicated most data were of moderate or high quality and there-
fore suitable for an adequacy evaluation.
  Results varied by country, with one or more countries achieving improvements in vitamin A and
iodine status, decreases in anaemia rates and malaria prevalence, higher rates of EBF and immuni-
zation and improved child growth.
  The magnitude of the nutrition and health impact was often larger than observed in controlled
interventions or trials.
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